5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.85▼ | 1.87▼ | 1.87▼ | 1.94▼ | 1.91▼ |
MA10 | 1.86▼ | 1.89▼ | 1.89▼ | 1.95▼ | 1.86▼ |
MA20 | 1.87▼ | 1.90▼ | 1.93▼ | 1.93▼ | 1.81▲ |
MA50 | 1.89▼ | 1.95▼ | 1.97▼ | 1.83▲ | 2.08▼ |
MA100 | 1.92▼ | 1.97▼ | 1.93▼ | 1.81▲ | 8.19▼ |
MA200 | 1.96▼ | 1.92▼ | 1.92▼ | 1.84▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.004▼ | -0.008▼ | -0.010▼ | 0.147▲ |
RSI | 39.564▼ | 31.099▼ | 30.975▼ | 44.243▼ | 41.244▼ |
STOCH | 24.405 | 15.888▼ | 17.335▼ | 53.296 | 80.157▲ |
WILL %R | -75.000 | -88.889▼ | -92.593▼ | -87.755▼ | -29.655 |
CCI | -104.730▼ | -156.579▼ | -147.982▼ | -69.340 | 71.488 |
RSI | $HLVX RSI(14) Crossed Below 50 | Set Alert |
Wednesday, May 21, 2025 08:38 PM
Every investor in HilleVax, Inc. (NASDAQ:HLVX) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 51% to be precise ...
|
Thursday, May 08, 2025 04:14 AM
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported ...
|
Friday, April 04, 2025 05:00 PM
HilleVax, Inc. (NASDAQ:HLVX – Get Free Report) has been given a consensus recommendation of “Hold” by the six analysts that are currently covering the company, MarketBeat.com reports.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 1.90 | 1.93 | 1.84 | 1.85 | 354,921 |
12/06/25 | 1.94 | 1.975 | 1.905 | 1.92 | 137,557 |
11/06/25 | 1.98 | 2.03 | 1.94 | 1.96 | 179,175 |
10/06/25 | 2.04 | 2.065 | 1.93 | 1.95 | 397,036 |
09/06/25 | 2.00 | 2.05 | 1.955 | 2.04 | 185,328 |
06/06/25 | 1.98 | 2.02 | 1.93 | 1.99 | 101,287 |
05/06/25 | 1.97 | 1.98 | 1.92 | 1.96 | 101,202 |
04/06/25 | 1.96 | 1.99 | 1.915 | 1.98 | 168,135 |
03/06/25 | 1.93 | 1.99 | 1.925 | 1.96 | 142,057 |
02/06/25 | 1.86 | 1.93 | 1.86 | 1.93 | 147,293 |
|
|
||||
|
|
||||
|
|